Benefits
Sustained energy and mental alertness
Axivite® provides energy and cognitive support through mechanisms targeting mental fatigue, focus, and alertness — designed for consumers seeking functional energy enhancement without traditional stimulant side effects.
Cognitive performance support
Supports focus, attention, and cognitive performance through evidence-informed ingredient selection in the energy and nootropic space.
Mechanism of action
Energy and cognitive pathway support
Specific mechanism pending full ingredient disclosure from SEE Nutrition. Based on positioning in energy and cognitive categories, likely involves adenosine receptor modulation, mitochondrial energy support, or neurotransmitter precursor provision.
Clinical trials
Axivite® is marketed as an energy and cognitive performance ingredient by SEE Nutrition / NXT Ingredients. As of current review, no peer-reviewed clinical trials specifically branded Axivite® appear in PubMed.
Animal/in-vitro mechanistic study. Mice (TAAR1 wildtype and knockout) tested with central administration of 3-methoxytyramine (3-MT, the active in Axivite®) at varying doses. Includes biochemical signaling assays (ERK and CREB phosphorylation in mouse striatum). NOT a human RCT — Axivite® has no PubMed-indexed human clinical trial published as of May 2026.
3-MT (the active in Axivite®) was confirmed as a NEUROMODULATOR acting independently of dopamine via the trace amine-associated receptor 1 (TAAR1). In normal mice, 3-MT caused temporary mild hyperactivity (mild stimulant-like effect). In mice acutely depleted of dopamine, 3-MT induced abnormal involuntary movements. ERK and CREB phosphorylation suggested PKA-mediated cAMP signaling. CAVEAT: This is foundational neuroscience showing the receptor mechanism — there is NO human RCT for Axivite® or 3-MT supplementation as of 2026. Branded product claims of "energy and cognitive performance" are extrapolated from this mechanistic basis. Formulators should treat as evidence-level 1-2 (mechanism only).